Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-GemOx vs R-miniCHOP in Elderly DLBCL
NCT02767674Phase 3Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2016
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, oxaliplatin in diffuse large B-cell lymphoma (DLBCL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02767674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767674.